跳到内容
Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research 预览资料
关闭预览资料
正在查...

Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research

著者: Nikhil C Munshi; Kenneth C Anderson
出版商: New York ; London : Springer, ©2013.
版本/格式:   电子图书 : 文献 : 英语查看所有的版本和格式
数据库:WorldCat
提要:
Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination  再读一些...
评估:

(尚未评估) 0 附有评论 - 争取成为第一个。

主题
更多类似这样的

 

在线查找

与资料的链接

在图书馆查找

&AllPage.SpinnerRetrieving; 正在查找有这资料的图书馆...

详细书目

类型/形式: Electronic books
附加的形体格式: Print version:
Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research.
New York ; London : Springer, 2012
(OCoLC)817270653
材料类型: 文献, 互联网资源
文件类型: 互联网资源, 计算机文档
所有的著者/提供者: Nikhil C Munshi; Kenneth C Anderson
ISBN: 9781461452607 1461452600
OCLC号码: 821823520
注意: Includes index.
描述: 1 online resource.
内容: Myeloma Immune and Antibody Targets --
T Cell Responses in Myeloma / Ross Brown, P. Joy Ho, John Gibson, Douglas Joshua --
Novel Antigenic Targets for Immunotherapy in Myeloma / Qing Yi --
Antibody-Based Therapies in Multiple Myeloma / Yu-Tzu Tai --
Defining Multiple Myeloma as a Target for DNA Vaccines / Surinder S. Sahota, Natalia Savelyeva, Debora Joseph-Pietras, Niklas Zojer --
Harnessing Allogeneic Immunity for Anti-myeloma Response / Roberto Bellucci, Edwin P. Alyea --
Dendritic Cells and Peptide-Based Vaccine In Multiple Myeloma / Jooeun Bae, R. H. Prabhala, Nikhil C. Munshi --
New Agents --
Novel Proteasome Inhibitors / Robert Z. Orlowski --
Newer IMiDs / Abhishek Singla, Shaji Kumar. --
Novel Agents in Multiple Myeloma / Anuj Mahindra, Jacob Laubach, Constantine Mitsiades, Paul Richardson --
Early Combination Studies in Multiple Myeloma / Alessandra Larocca, Antonio Palumbo --
The Effect of Novel Anti-myeloma Agents on Bone Metabolism / Evangelos Terpos. T cell responses in myeloma --
Novel antigenic targets for immunotherapy in myeloma --
Antibody-based therapies in Multiple Myeloma --
Defining multiple myeloma as a target for DNA gene fusion vaccines --
Harnessing allogeneic immunity for anti-myeloma response --
Dendritic cell and peptide-based vaccination in myeloma --
New Proteasome inhibitors --
Newer Imids --
New agents in myeloma --
Early Combination Studies in MM --
The effect of novel antimyeloma agents on bone metabolism --
Index.\
其他题名: Translational and clinical research
责任: edited by Nikhil C. Munshi, Kenneth C. Anderson.
更多信息:

摘要:

This volume focuses on the biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel  再读一些...

评论

用户提供的评论
正在获取GoodReads评论...
正在检索DOGObooks的评论

标签

争取是第一个!
确认申请

你可能已经申请过这份资料。如果还是想申请,请选确认。

链接数据


<http://www.worldcat.org/oclc/821823520>
library:oclcnum"821823520"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/821823520>
rdf:typeschema:Book
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact."
schema:description"T cell responses in myeloma -- Novel antigenic targets for immunotherapy in myeloma -- Antibody-based therapies in Multiple Myeloma -- Defining multiple myeloma as a target for DNA gene fusion vaccines -- Harnessing allogeneic immunity for anti-myeloma response -- Dendritic cell and peptide-based vaccination in myeloma -- New Proteasome inhibitors -- Newer Imids -- New agents in myeloma -- Early Combination Studies in MM -- The effect of novel antimyeloma agents on bone metabolism -- Index.\"
schema:exampleOfWork<http://worldcat.org/entity/work/id/2022960558>
schema:genre"Electronic books."
schema:inLanguage"en"
schema:name"Translational and clinical research"
schema:name"Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research"
schema:publisher
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=523058>
schema:url<http://site.ebrary.com/id/10634854>
schema:url
schema:url<http://lib.myilibrary.com?id=424647>
schema:url<http://dx.doi.org/10.1007/978-1-4614-5260-7>
schema:workExample

Content-negotiable representations

关闭窗口

请登入WorldCat 

没有张号吗?很容易就可以 建立免费的账号.